Learn more about whether Moderna, Inc. or TG Therapeutics, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

The Mead Group at UNC Wilmington studies the occurrence and transport PFAS in wet and dry depositions, tracing their sources to inform regulators. In the first part of our interview, we spoke with ...

Learn more about whether Alvotech or TG Therapeutics, Inc. is a better investment based on AAII's A+ Investor grades, which ...

The field of gene editing recently got a major boost from Massachusetts-based Beam Therapeutics, and the company’s Durham ...

If you wait too long, you miss them. For much of the season, North Carolina has hit the snooze button when dawn arrived. Despite the several instances of oversleeping, it kept getting chances to ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

Check Out Our Latest Analysis on United Therapeutics United Therapeutics Stock Down 1.6 % UTHR stock opened at $313.60 on Wednesday. United Therapeutics has a 52-week low of $221.53 and a 52-week ...

The earthquake was reported early Wednesday morning. It was reported at 5:09 a.m. Wednesday 6 kilometers east-southeast of Elgin. That's located in Kershaw County. The earthquake had a magnitude of ...

The overall quant rating is not an average of the factor grades listed. Instead, it gives greater weight to the metrics with the strongest predictive value.

Prepac officials, however, told a local publication that the environment in question long predated new concerns about tariffs: North Carolina, CEO Nick Bozikis told Business in Vancouver ...

BofA lowered the firm’s price target on United Therapeutics (UTHR) to $314 from $328 and keeps an Underperform rating on the shares. The firm thinks the challenges to owning United in 2025 are ...